Find Tolterodine Tartrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

FDF DossiersDRUG PRODUCT COMPOSITIONS

222RELATED EXCIPIENT COMPANIES

347EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

GLOBAL SALES INFORMATION

Annual Reports

NA

MARKET PLACE

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Tolterodine tartrate, 124937-52-6, Detrol la, Detrusitol, Tolterodine l-tartrate, Pnu-200583e
Molecular Formula
C26H37NO7
Molecular Weight
475.6  g/mol
InChI Key
TWHNMSJGYKMTRB-KXYUELECSA-N
FDA UNII
5T619TQR3R

Tolterodine Tartrate
An ANTIMUSCARINIC AGENT selective for the MUSCARINIC RECEPTORS of the BLADDER that is used in the treatment of URINARY INCONTINENCE and URINARY URGE INCONTINENCE.
1 2D Structure

Tolterodine Tartrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,3R)-2,3-dihydroxybutanedioic acid;2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol
2.1.2 InChI
InChI=1S/C22H31NO.C4H6O6/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24;5-1(3(7)8)2(6)4(9)10/h6-12,15-17,20,24H,13-14H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t20-;1-,2-/m11/s1
2.1.3 InChI Key
TWHNMSJGYKMTRB-KXYUELECSA-N
2.1.4 Canonical SMILES
CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(C(C(=O)O)O)(C(=O)O)O
2.1.5 Isomeric SMILES
CC1=CC(=C(C=C1)O)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
2.2 Other Identifiers
2.2.1 UNII
5T619TQR3R
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Detrol La

2. Detrusitol

3. Pha 686464b

4. Pha-686464b

5. Pha686464b

6. Tartrate, Tolterodine

7. Tolterodine

8. Tolterodine Tartrate

9. Unidet

10. Urotrol

2.3.2 Depositor-Supplied Synonyms

1. Tolterodine Tartrate

2. 124937-52-6

3. Detrol La

4. Detrusitol

5. Tolterodine L-tartrate

6. Pnu-200583e

7. (r)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-methylphenol (2r,3r)-2,3-dihydroxysuccinate

8. Tolterodine Tartrate [usan]

9. Kabi-2234

10. Urotrol

11. 5t619tqr3r

12. Pnu 200583e

13. Tolterodine Tartrate (detrol La)

14. 124937-52-6 (tartrate)

15. Tolterodine (tartrate)

16. (r)-2-(3-diisopropylamino-1-phenyl-propyl)-p-cresol L-tartrate

17. (r)-2-(3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methylphenol (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1) (salt)

18. (+)-(r)-2-(i-(2-(diisopropylamino)ethyl)benzyl)-p-cresol L-tartrate (1:1) (salt)

19. Unii-5t619tqr3r

20. (2r,3r)-2,3-dihydroxybutanedioic Acid;2-[(1r)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol

21. Detrusitol Sr

22. Mfcd07771985

23. (r)-2-[3-(diisopropylamino)-1-phenylpropyl]-4-methylphenol L-tartrate

24. Detrusitol (tn)

25. Detrol (tn)

26. Tolterodine, Tartrate

27. (tolterodine Tartrate)

28. Detrol La;kabi-2234;pnu-200583e

29. Tolterodine Tartrate,(s)

30. (r)-tolterodine L-tartrate

31. Tolterodine Tartrate- Bio-x

32. Mls003915640

33. Schembl467372

34. Chembl1200871

35. Tolterodine Tartrate (jan/usp)

36. Dtxsid80924972

37. Tolterodine Tartrate [mi]

38. Hms3715n08

39. Hms3884j08

40. Tolterodine Tartrate [jan]

41. Tolterodine Tartrate [vandf]

42. S2550

43. Tolterodine Tartrate [mart.]

44. Tolterodine Tartrate [usp-rs]

45. Akos015961803

46. Ac-2617

47. Ccg-221263

48. Cs-0441

49. Ds-1398

50. Tolterodine L-tartrate [who-dd]

51. Tolterodine L-tartrate 124937-51-5

52. (2r,3r)-2,3-dihydroxybutanedioic Acid,2-[(1r)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol

53. As-35344

54. Bt164484

55. Hy-90010

56. Phenol, 2-((1r)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methyl-, (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)

57. Phenol, 2-(3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methyl-, (r)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1) (salt)

58. Smr002544692

59. Tolterodine L-tartrate, >=98% (hplc)

60. Tolterodine Tartrate [orange Book]

61. Bcp0726000292

62. Tolterodine Tartrate [ep Monograph]

63. Tolterodine Tartrate [usp Monograph]

64. Sw197495-2

65. D01148

66. (r)-2-(3-(diisopropylamino)-1-phenylpropyl)-

67. 4-methylphenol (2r,3r)-2,3-dihydroxysuccinate

68. 937t526

69. A890340

70. J-500064

71. Q27114836

72. (+)-(r)-2-(a-[2-(diisopropylamino)ethyl]benzyl)-p-cresol Tartrate

73. (+)-r)-2-{a-(2-(diisopropylamino)ethyl)benzyl}-p-cresol Tartrate

74. (r)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-methylphenol(2r,3r)-2,3-dihydroxysuccinate

75. (r)-2-(3-diisopropylamino-1-phenyl-propyl)-4-methyl-phenol L-tartrate

76. 2-[(1r)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol (2r,3r)-2,3-dihydroxybutanedioate

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 475.6 g/mol
Molecular Formula C26H37NO7
Hydrogen Bond Donor Count5
Hydrogen Bond Acceptor Count8
Rotatable Bond Count10
Exact Mass475.25700252 g/mol
Monoisotopic Mass475.25700252 g/mol
Topological Polar Surface Area139 Ų
Heavy Atom Count34
Formal Charge0
Complexity474
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 6  
Drug NameDetrol
PubMed HealthTolterodine (By mouth)
Drug ClassesUrinary Antispasmodic
Drug LabelDETROL Tablets contain tolterodine tartrate. The active moiety, tolterodine, is a muscarinic receptor antagonist. The chemical name of tolterodine tartrate is (R)-2-[3-[bis(1-methylethyl)-amino]1-phenylpropyl]-4-methylphenol [R-(R*,R*)]-2,3dihydroxyb...
Active IngredientTolterodine tartrate
Dosage FormTablet
RouteOral
Strength2mg; 1mg
Market StatusPrescription
CompanyPharmacia And Upjohn

2 of 6  
Drug NameDetrol la
Drug LabelDETROL LA Capsules contain tolterodine tartrate. The active moiety, tolterodine, is a muscarinic receptor antagonist. The chemical name of tolterodine tartrate is (R)-N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine L-hydrogen tartrat...
Active IngredientTolterodine tartrate
Dosage FormCapsule, extended release
RouteOral
Strength4mg; 2mg
Market StatusPrescription
CompanyPharmacia And Upjohn

3 of 6  
Drug NameTolterodine tartrate
PubMed HealthTolterodine (By mouth)
Drug ClassesUrinary Antispasmodic
Drug LabelTolterodine tartrate tablets contain tolterodine tartrate. The active moiety, tolterodine, is a muscarinic receptor antagonist. The chemical name of tolterodine tartrate is (+)-(R)-2-[I-[2-(Diisopropylamino)ethyl]benzyl]-p-cresol L-tartrate (1:1) (sa...
Active IngredientTolterodine tartrate
Dosage FormTablet; Capsule, extended release
Routeoral; Oral
Strength1mg; 4mg; 2mg
Market StatusTentative Approval; Prescription
CompanyMylan Pharms; Apotex; Sandoz

4 of 6  
Drug NameDetrol
PubMed HealthTolterodine (By mouth)
Drug ClassesUrinary Antispasmodic
Drug LabelDETROL Tablets contain tolterodine tartrate. The active moiety, tolterodine, is a muscarinic receptor antagonist. The chemical name of tolterodine tartrate is (R)-2-[3-[bis(1-methylethyl)-amino]1-phenylpropyl]-4-methylphenol [R-(R*,R*)]-2,3dihydroxyb...
Active IngredientTolterodine tartrate
Dosage FormTablet
RouteOral
Strength2mg; 1mg
Market StatusPrescription
CompanyPharmacia And Upjohn

5 of 6  
Drug NameDetrol la
Drug LabelDETROL LA Capsules contain tolterodine tartrate. The active moiety, tolterodine, is a muscarinic receptor antagonist. The chemical name of tolterodine tartrate is (R)-N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropanamine L-hydrogen tartrat...
Active IngredientTolterodine tartrate
Dosage FormCapsule, extended release
RouteOral
Strength4mg; 2mg
Market StatusPrescription
CompanyPharmacia And Upjohn

6 of 6  
Drug NameTolterodine tartrate
PubMed HealthTolterodine (By mouth)
Drug ClassesUrinary Antispasmodic
Drug LabelTolterodine tartrate tablets contain tolterodine tartrate. The active moiety, tolterodine, is a muscarinic receptor antagonist. The chemical name of tolterodine tartrate is (+)-(R)-2-[I-[2-(Diisopropylamino)ethyl]benzyl]-p-cresol L-tartrate (1:1) (sa...
Active IngredientTolterodine tartrate
Dosage FormTablet; Capsule, extended release
Routeoral; Oral
Strength1mg; 4mg; 2mg
Market StatusTentative Approval; Prescription
CompanyMylan Pharms; Apotex; Sandoz

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Muscarinic Antagonists

Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)


Urological Agents

Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
Cholinergic Muscarinic Antagonists [MoA]; Cholinergic Muscarinic Antagonist [EPC]

USDMF

read-more
read-moreread-more

01

Interquim Sa

Spain
arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Flag Spain
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2013-04-23

Pay. Date : 2013-04-10

DMF Number : 19599

Submission : 2006-07-14

Status : Active

Type : II

Interquim

02

Amino Chemicals Ltd

Malta

USDMF

arrow
Arvo
Not Confirmed

03

Arvo
Not Confirmed

03

Arvo
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2016-02-25

Pay. Date : 2015-09-24

DMF Number : 19649

Submission : 2006-07-31

Status : Active

Type : II

blank

04

Cipla Ltd

India

USDMF

arrow
Arvo
Not Confirmed

04

Cipla Ltd

India
arrow
Arvo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 17018

Submission : 2003-12-11

Status : Active

Type : II

blank

05

Itf Chemical Ltda

Brazil

USDMF

arrow
Arvo
Not Confirmed

05

Arvo
Not Confirmed

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 19510

Submission : 2006-06-07

Status : Inactive

Type : II

blank

07

Arvo
Not Confirmed

08

Arvo
Not Confirmed
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

CEP/COS

read-more
read-moreread-more
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Flag Spain
Digital Content Digital Content
R1-CEP 2015-301 - Rev 01
Valid
Chemical
2022-07-18
2781
Interquim

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Flag Spain
Digital Content Digital Content

Certificate Number : R1-CEP 2015-301 - Rev 01

Status : Valid

Issue Date : 2022-07-18

Type : Chemical

Substance Number : 2781

Interquim
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEuropean CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Flag Poland
Digital Content Digital Content
R1-CEP 2015-192 - Rev 00
Valid
Chemical
2021-08-30
2781
Polpharma CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEuropean CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Flag Poland
Digital Content Digital Content

Certificate Number : R1-CEP 2015-192 - Rev 00

Status : Valid

Issue Date : 2021-08-30

Type : Chemical

Substance Number : 2781

Polpharma CB

03

Arvo
Not Confirmed
arrow

04

Arvo
Not Confirmed
arrow

05

Arvo
Not Confirmed
arrow

06

Arvo
Not Confirmed
arrow

07

Arvo
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMaithri Drugs: Dedicated to your API needs.

Flag India
Digital Content Digital Content

Tolterodine Tartarate USP/EP

Date of Issue : 2026-02-24

Valid Till : 2029-02-23

Written Confirmation Number : WC-0455

Address of the Firm : Sy No. 14, IDA Gaddapotharam, Gaddapotharam (V), Jinnaram (M), Sangareddy (D), T...

Company Banner

02

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolterodine Tartrate EP

Date of Issue : 2025-08-08

Valid Till : 2028-06-10

Written Confirmation Number : WC-0017

Address of the Firm : Unit-II, SurveyNo.:10&13,Gaddapotharam (Village), IDA-Kazipally, Jinnaram (Manda...

blank

03

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolterodine Tartrate USP

Date of Issue : 2024-05-07

Valid Till : 2027-04-02

Written Confirmation Number : WC-491n

Address of the Firm : Plot No. 152 & 160, Phase-V, IDA Jeedimetla, Hyderabad., Jeedimetla (V), Quthbul...

blank

04

Hetero Drugs

India
Arvo
Not Confirmed
arrow

Hetero Drugs

India
arrow
Arvo
Not Confirmed

Tolterodine Tartrate IH/USP/EP

Date of Issue : 2025-09-19

Valid Till : 2028-07-03

Written Confirmation Number : WC-0040

Address of the Firm : Unit-l, Sy. No. 213, 214 & 255, Bonthapally (Village),Gummadidala (Mandal), Sang...

blank

05

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolterodine Tartrate IH

Date of Issue : 2025-11-12

Valid Till : 2028-11-10

Written Confirmation Number : WC-0079

Address of the Firm : Plot No. - 2209, G.I.D.C., Sarigam - 396 155, Dist - Valsad, Gujarat, India

blank

06

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolterodine Tartrate IP/IH/USP/EP

Date of Issue : 2025-10-17

Valid Till : 2028-07-07

Written Confirmation Number : WC-0230

Address of the Firm : Plot No.24, 25 & 26, Phase-I, IDA, Jeedimetla, Medchai District-500 055, Telanga...

blank

07

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolterodine Tartrate USP

Date of Issue : 2025-09-19

Valid Till : 2028-07-27

Written Confirmation Number : WC-0062

Address of the Firm : Plot No. 197, Sector -I, Pithampur -454775, District -Dhar (MP), India.

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

Interquim SA

Spain
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Flag Spain
Digital Content Digital Content

tolterodine tartrate

Registrant Name : Seongwoo Chemical Co., Ltd.

Registration Date : 2020-07-14

Registration Number : 20200714-209-J-584

Manufacturer Name : Interquim, SA

Manufacturer Address : c/ Joan Buscallà, 10, 08173 Sant Cugat Del Vallès (Barcelona), Spain

Interquim

02

Interquim SA

Spain
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Flag Spain
Digital Content Digital Content

tolterodine tartrate

Registrant Name : Kyungdong Pharmaceutical Co., Ltd.

Registration Date : 2020-11-06

Registration Number : 20200714-209-J-584(1)

Manufacturer Name : Interquim, SA

Manufacturer Address : c/ Joan Buscallà, 10, 08173 Sant Cugat Del Vallès (Barcelona), Spain

Interquim

03

Hetero Drugs

India
AOCS Annual Meeting
Not Confirmed
arrow

Hetero Drugs

India
arrow
AOCS Annual Meeting
Not Confirmed

tolterodine tartrate

Registrant Name : Lee Sung International Co., Ltd.

Registration Date : 2021-05-04

Registration Number : 20210504-209-J-973

Manufacturer Name : Hetero Drugs Limited (Unit-I...

Manufacturer Address : Sy. No. 213, 214 & 255, Bonthapally Village, Gummadidala Mandal Sangareddy District 5...

blank

04

Korea Biochem Pharm

South Korea
AOCS Annual Meeting
Not Confirmed
arrow

Korea Biochem Pharm

South Korea
arrow
AOCS Annual Meeting
Not Confirmed

Tolterodine-L-tartrate

Registrant Name : Korea Biochem Pharmaceutical Co., Ltd.

Registration Date : 2023-06-05

Registration Number : 20230605-209-J-1505

Manufacturer Name : Korea Biochem Pharmaceutical...

Manufacturer Address : 204 Sandan-gil, Jeonui-myeon, Sejong Special Self-Governing City

blank

05

AOCS Annual Meeting
Not Confirmed
arrow
arrow
AOCS Annual Meeting
Not Confirmed

tolterodine tartrate

Registrant Name : Pamire Co., Ltd.

Registration Date : 2020-08-18

Registration Number : 20200818-209-J-718

Manufacturer Name : Macleods Pharmaceuticals Lim...

Manufacturer Address : Plot No. 2209, GIDC Industrial Estate., At & Post: Sarigam, Tal-Umbergaon, City: Sari...

blank

06

Pfizer Inc

U.S.A
AOCS Annual Meeting
Not Confirmed
arrow

Pfizer Inc

U.S.A
arrow
AOCS Annual Meeting
Not Confirmed

Tolterodine-L-tartrate

Registrant Name : Beatris Korea Co., Ltd.

Registration Date : 2021-06-01

Registration Number : 20210601-209-J-907

Manufacturer Name : Viatris Pharmaceuticals LLC

Manufacturer Address : Po Box 628 Road No. 2 KM 58.2 Barceloneta, Puerto Rico 00617

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Flag India
Digital Content Digital Content

TOLTERODINE TARTRATE

NDC Package Code : 55111-855

Start Marketing Date : 2004-10-06

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPfizer CentreOne is a global CDMO and a leading supplier of Specialty APIs.

Flag U.S.A
Digital Content Digital Content

TOLTERODINE TARTRATE

NDC Package Code : 0009-0420

Start Marketing Date : 2014-07-03

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

Pfizer centreOne

03

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

TOLTERODINE TARTRATE

NDC Package Code : 65862-394

Start Marketing Date : 2024-01-10

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (50kg/50kg)

Marketing Category : BULK INGREDIENT

blank

04

Cipla Ltd.

India
Arvo
Not Confirmed
arrow

Cipla Ltd.

India
arrow
Arvo
Not Confirmed

TOLTERODINE TARTRATE

NDC Package Code : 53104-7572

Start Marketing Date : 2016-01-01

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (25kg/25kg)

Marketing Category : BULK INGREDIENT

blank

05

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

TOLTERODINE TARTRATE

NDC Package Code : 49706-1835

Start Marketing Date : 2010-01-08

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

06

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

TOLTERODINE TARTRATE

NDC Package Code : 65977-0029

Start Marketing Date : 1998-03-25

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

07

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

TOLTERODINE TARTRATE

NDC Package Code : 50370-0023

Start Marketing Date : 2010-04-20

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

08

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

TOLTERODINE TARTRATE

NDC Package Code : 71666-009

Start Marketing Date : 2020-03-28

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

09

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

TOLTERODINE TARTRATE

NDC Package Code : 53747-035

Start Marketing Date : 2011-09-29

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

10

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

TOLTERODINE

NDC Package Code : 65427-022

Start Marketing Date : 2014-07-03

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Interquim SA

Spain
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInterquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Flag Spain
Digital Content Digital Content

Tolterodine Tartrate

About the Company : Interquim, founded in 1978 and part of Ferrer HealthTech, develops high-value APIs with strict quality standards. Its facilities comply with European regulations, and products are ...

Interquim, founded in 1978 and part of Ferrer HealthTech, develops high-value APIs with strict quality standards. Its facilities comply with European regulations, and products are exported to regulated markets. Approved by regulators and clients, Interquim supports clients from development to marketing with advanced production and quality-control labs. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Interquim

02

Polpharma

Poland
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothEuropean CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

Flag Poland
Digital Content Digital Content

Tolterodine Tartrate

About the Company : Polpharma API, a division of a leading Polish pharmaceutical group, has over 75 years of expertise in process development and cGMP manufacturing. Based at an FDA-approved site in C...

Polpharma API, a division of a leading Polish pharmaceutical group, has over 75 years of expertise in process development and cGMP manufacturing. Based at an FDA-approved site in Central Europe, it offers comprehensive API services from development to scale-up. Specializing in small molecule clinical candidates, Polpharma delivers customized, high-quality solutions with strong regulatory knowledge and advanced infrastructure. Globally recognized for complex chemistry, it is committed to precision, partnership, and progress. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
Polpharma CB

03

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Tolterodine Tartrate

About the Company : LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product ...

LGM Pharma is a global leader in sourcing APIs, including hard-to-find drug substances, for pharmaceutical and biotech industries. LGM also operates as a full-service drug product CDMO, offering formulation, analytical method development and testing, regulatory support, and commercial manufacturing. Supported by a network of over 220 accredited cGMP manufacturing partners and more than 100,000 sq. ft. of FDA-inspected cGMP manufacturing and warehouse space, LGM delivers secure, end-to-end solutions across multiple dosage forms. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
LGM Pharma CB

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMetrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Flag India
Digital Content Digital Content

Tolterodine Tartrate

About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...

Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product groups and has been approved by ISO 9001-2015, USFDA, WHO GMP, Cofepris & Japanese authorities. Metrochem’s in-depth industry knowledge, & hi-tech & advanced infrastructure, helps it provide quality products to its customers. Note: None of the products will be supplied to the countries where this could conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer
Metrochem

05

HRV Pharma

India
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Pharma - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Tolterodine Tartrate

About the Company : HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing...

HRV Pharma is a global manufacturer, seller, and exporter of APIs, intermediates, pellets, food-grade chemicals, food additives, and food ingredients. The company provides sourcing, manufacturing, and supply services to support partners entering new markets worldwide. HRV Pharma works closely with major pharma and food additive companies and represents over 30 Indian drugmakers, primarily serving Europe, the US, and the Middle East. Headquartered in India, it operates offices in the US, Switzerland, Dubai, Lithuania, and Turkey. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
HRV Global Life Sciences

06

Pharmathen SA

Greece
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Flag Greece
Digital Content Digital Content

Tolterodine

About the Company : Pharmathen, established in 1969, has emerged as a leading in-house development partner in Europe. It specializes in the development, registration, manufacturing & life-cycle manage...

Pharmathen, established in 1969, has emerged as a leading in-house development partner in Europe. It specializes in the development, registration, manufacturing & life-cycle management of complex pharmaceutical technologies & generic formulations. With a portfolio of over 100 products, Pharmathen serves over 250 clients across 80 countries. It’s pipeline includes advanced long-acting injectables, sustained-release formulations & preservative-free ophthalmics manufactured in USFDA & EU-approved facilities. Pharmathen’s core technology platforms, including microspheres, nanosuspensions & nanogels, are used to develop long-acting therapies.
Pharmathen

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content

Tolterodine Tartrate

About the Company : Founded in 1935, TAPI Technology & API Services has a long legacy of advancing health through innovation. Today, we offer one of the industry’s most comprehensive API portfolios ...

Founded in 1935, TAPI Technology & API Services has a long legacy of advancing health through innovation. Today, we offer one of the industry’s most comprehensive API portfolios with over 350 products, alongside tailored CDMO services. Leveraging deep expertise and diverse technologies, we deliver flexible, high-quality solutions to meet our partners’ needs. Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
TAPI Company Banner

08

Anwita Drugs

India
Arvo
Not Confirmed
arrow

Anwita Drugs

India
arrow
Arvo
Not Confirmed

Tolterodine Tartrate

About the Company : Anwita Drugs is a technocrat-driven pharmaceutical company with over 28 years of expertise in designing and developing solid oral dosage forms (OSD), nutraceuticals, and dietary su...

Anwita Drugs is a technocrat-driven pharmaceutical company with over 28 years of expertise in designing and developing solid oral dosage forms (OSD), nutraceuticals, and dietary supplements. We specialize in the design, development, and optimization of solid, semi-solid, and liquid applications using cutting-edge technology. With strong R&D capabilities and a focus on niche product manufacturing, we deliver cost-effective, high-quality solutions. Our mission is to provide integrated, efficient services across multi-therapeutic domains.
blank

09

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolterodine Tartrate

About the Company : Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company comme...

Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others.
blank

10

Arvo
Not Confirmed
arrow
arrow
Arvo
Not Confirmed

Tolterodine

About the Company : Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and...

Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - TABLET;ORAL - 1MG

USFDA APPLICATION NUMBER - 20771

read-more

DOSAGE - TABLET;ORAL - 2MG

USFDA APPLICATION NUMBER - 20771

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 2MG

USFDA APPLICATION NUMBER - 21228

read-more

DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 4MG

USFDA APPLICATION NUMBER - 21228

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Coating Systems & Additives

read-more
read-more

Lubricants & Glidants

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Granulation

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Direct Compression

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Topical

read-more
read-more

Taste Masking

read-more
read-more

Co-Processed Excipients

read-more
read-more

Solubilizers

read-more
read-more

Empty Capsules

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Emulsifying Agents

read-more
read-more

API Stability Enhancers

read-more
read-more

Parenteral

read-more
read-more

Vegetarian Capsules

read-more
read-more

Rheology Modifiers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Coloring Agents

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ANALYTICAL

Upload your methods for free, ask us

ABOUT THIS PAGE

Looking for 124937-52-6 / Tolterodine Tartrate API manufacturers, exporters & distributors?

Tolterodine Tartrate manufacturers, exporters & distributors 1

78

PharmaCompass offers a list of Tolterodine Tartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Tolterodine Tartrate manufacturer or Tolterodine Tartrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tolterodine Tartrate manufacturer or Tolterodine Tartrate supplier.

API | Excipient name

Tolterodine Tartrate

Synonyms

124937-52-6, Detrol la, Detrusitol, Tolterodine l-tartrate, Pnu-200583e, (r)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-methylphenol (2r,3r)-2,3-dihydroxysuccinate

Cas Number

124937-52-6

Unique Ingredient Identifier (UNII)

5T619TQR3R

About Tolterodine Tartrate

An ANTIMUSCARINIC AGENT selective for the MUSCARINIC RECEPTORS of the BLADDER that is used in the treatment of URINARY INCONTINENCE and URINARY URGE INCONTINENCE.

Urotrol Manufacturers

A Urotrol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Urotrol, including repackagers and relabelers. The FDA regulates Urotrol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Urotrol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Urotrol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

Urotrol Suppliers

A Urotrol supplier is an individual or a company that provides Urotrol active pharmaceutical ingredient (API) or Urotrol finished formulations upon request. The Urotrol suppliers may include Urotrol API manufacturers, exporters, distributors and traders.

click here to find a list of Urotrol suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

Urotrol USDMF

A Urotrol DMF (Drug Master File) is a document detailing the whole manufacturing process of Urotrol active pharmaceutical ingredient (API) in detail. Different forms of Urotrol DMFs exist exist since differing nations have different regulations, such as Urotrol USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Urotrol DMF submitted to regulatory agencies in the US is known as a USDMF. Urotrol USDMF includes data on Urotrol's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Urotrol USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Urotrol suppliers with USDMF on PharmaCompass.

Urotrol KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Urotrol Drug Master File in Korea (Urotrol KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Urotrol. The MFDS reviews the Urotrol KDMF as part of the drug registration process and uses the information provided in the Urotrol KDMF to evaluate the safety and efficacy of the drug.

After submitting a Urotrol KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Urotrol API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Urotrol suppliers with KDMF on PharmaCompass.

Urotrol CEP

A Urotrol CEP of the European Pharmacopoeia monograph is often referred to as a Urotrol Certificate of Suitability (COS). The purpose of a Urotrol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Urotrol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Urotrol to their clients by showing that a Urotrol CEP has been issued for it. The manufacturer submits a Urotrol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Urotrol CEP holder for the record. Additionally, the data presented in the Urotrol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Urotrol DMF.

A Urotrol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Urotrol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Urotrol suppliers with CEP (COS) on PharmaCompass.

Urotrol WC

A Urotrol written confirmation (Urotrol WC) is an official document issued by a regulatory agency to a Urotrol manufacturer, verifying that the manufacturing facility of a Urotrol active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Urotrol APIs or Urotrol finished pharmaceutical products to another nation, regulatory agencies frequently require a Urotrol WC (written confirmation) as part of the regulatory process.

click here to find a list of Urotrol suppliers with Written Confirmation (WC) on PharmaCompass.

Urotrol NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Urotrol as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Urotrol API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Urotrol as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Urotrol and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Urotrol NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Urotrol suppliers with NDC on PharmaCompass.

Urotrol GMP

Urotrol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Urotrol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Urotrol GMP manufacturer or Urotrol GMP API supplier for your needs.

Urotrol CoA

A Urotrol CoA (Certificate of Analysis) is a formal document that attests to Urotrol's compliance with Urotrol specifications and serves as a tool for batch-level quality control.

Urotrol CoA mostly includes findings from lab analyses of a specific batch. For each Urotrol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Urotrol may be tested according to a variety of international standards, such as European Pharmacopoeia (Urotrol EP), Urotrol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Urotrol USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty